Margy Visit 1 - 47-Year-Old Woman with Severe Hypertriglyceridemia and Type II Diabetes


Margy Visit 1 - 47-Year-Old Woman with Severe Hypertriglyceridemia and Type II Diabetes

Topic: Cardiology
Relevant Terms: Diabetes, Endocrinology, Hyperlipidemia
Primary Audience: Pharmacists, Physician Assistants, Physicians; Nurses and Registered Dietitians interested in lipid management.
Launch Date: 19-Aug-09
Credits: 0.5 AMA PRA Category 1 Credit
0.5 ACPE contact hour
0.5 ANCC contact hour
0.5 CDR continuing professional education unit
Expiration Date: The accreditation for this activity has expired.

Learning Objectives

After completion of this activity, participants should be better able to:

  1. Analyze the therapeutic benefit of nutrition, physical activity, and pharmaceutical agents in the management of patients with combined or mixed dyslipidemia.
  2. Compose a clinical care plan for reducing risk of CVD in patients with dyslipidemia.
  3. Define treatment goals for patients with mixed dyslipidemia based on the latest guidelines for lipid management issued by the NCEP.
  4. Describe the potential effects of elevated TGs and non-HDL-C on CVD risk and patient outcomes.


Christie M. Ballantyne, MD
Professor of Medicine
Baylor College of Medicine
Section of Atherosclerosis and Vascular Medicine
Maria and Alando J. Ballantyne, MD Atherosclerosis Clinical Research Laboratory
Center for Cardiovascular Disease Prevention
Methodist DeBakey Heart Center
Lipid Metabolism and Atherosclerosis Clinic
The Methodist Hospital
Houston, TX
Harold E. Bays, MD
Medical Director/President
Louisville Metabolic and Atherosclerosis Research Center, Inc. (L-MARC)
Louisville, KY
Tara Lynn Dall, MD
Medical Director/President
Advanced Lipidology
Delafield, WI
This continuing education activity is sponsored by the National Lipid Association and organized by Vindico Medical Education.

Target Audience
This activity is designed to meet the needs of physicians, physician assistants, pharmacists, nurses and registered dietitians interested in lipid management.

CME credit provided by the National Lipid Association.
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The National Lipid Association designates this educational activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

AKH Inc. is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 0.5 continuing professional education units (CPEUs) for completion of this program/material. Provider #AN008. The focus of this activity is rated Level 3.

AKH Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC-COA).

AKH Inc. designates this educational activity for .5 contact hours (0.05 CEU). Accreditation applies solely to educational activities and does not imply approval or endorsement of any commercial product by the ANCC-COA.

AKH Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc. approves this knowledge-based activity for .5 contact hours (0.05 CEU). UAN 077-999-09-037-H01-P.

To Obtain CME and CE Credits This activity includes text and graphics and may include multimedia features. Click on all of the medical education activity links and review the content presented. This activity should take approximately 30 minutes to complete.
  • Read, complete, and submit answers to the examination and evaluation questions online.
  • You must score 70% or higher to receive credit for this activity.
  • Once you have successfully completed the examination and evaluation, a certificate will be automatically generated.
Faculty Disclosure Statement
The National Lipid Association and AKH Inc. adhere to ACCME essential areas and policies, and ACPE and ANCC standards regarding industry support of CME/CE. Disclosure of faculty and commercial relationships, if any, are listed below. Identified conflicts are resolved prior to the certification of the activity.

Christie M. Ballantyne, MD:
· Grant Research Support: Abbott Laboratories, Inc., AstraZeneca, GlaxoSmithKline, Merck & Co., Sanofi-Synthelabo, Schering-Plough, Takeda Pharmaceuticals
· Consultant: Abbott Laboratories, Inc., AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, KOWA, Merck & Co., Merck/Schering Plough Pharmaceuticals, Metabasis, Novartis, Pfizer Inc., Sanofi-Synthelabo, Schering-Plough, Takeda Pharmaceuticals
· Speakers Bureau: AstraZeneca, GlaxoSmithKline, Merck & Co., Merck/Schering-Plough Pharmaceuticals, Pfizer Inc., Schering-Plough
· Honorarium: Abbott Laboratories, Inc., AstraZeneca, GlaxoSmithKline, Merck & Co., Merck/Schering-Plough Pharmaceuticals, Novartis, Pfizer Inc., Sanofi-Synthelabo, Schering-Plough, Takeda Pharmaceuticals

Harold E. Bays, MD:
· Research Grant: GlaxoSmithKline
· Consultant/Speaker: GlaxoSmithKline

Tara Lynn Dall, MD:
· Speakers Bureau: AstraZeneca, Abbott Laboratories, Inc., GlaxoSmithKline, LipoScience, Merck & Co.

Unlabeled and Investigational Usage
The participant is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Commercial Support
This continuing education activity is supported by an educational grant from GlaxoSmithKline.

ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities.

Disclaimer – Vindico Medical Education
The material presented at or in any National Lipid Association (NLA) continuing education activity does not necessarily reflect the views and opinions of the NLA, AKH Inc, or the organizer, Vindico Medical Education. Neither NLA, AKH Inc, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the U.S. Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.